Request Demo
Last update 05 Apr 2025
Recanaclotide
Last update 05 Apr 2025
Overview
Basic Info
Drug Type Synthetic peptide |
Synonyms Recanaclotide (USAN/INN), IW-9179 |
Target |
Action agonists |
Mechanism GC-C agonists(Heat-stable enterotoxin receptor agonists) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure/Sequence
Molecular FormulaC45H71N14O20PS6 |
InChIKeyGIUNZSCFWBGNLR-PHGSZHDLSA-N |
CAS Registry1667762-62-0 |
Sequence Code 183368
Source: *****
Related
3
Clinical Trials associated with RecanaclotideNCT02289846
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Phase 2a Study of Oral IW-9179 Administered Once and Twice Daily for 4 Weeks to Patients With Diabetic Gastroparesis
EUCTR2012-002748-25-BE
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Phase 2a Study of Oral IW-9179 Administered Once Daily for 14 Days to Patients with Functional Dyspesia
NCT01712412
Phase 2a Study of IW-9179 to Treat Functional Dyspepsia
100 Clinical Results associated with Recanaclotide
Login to view more data
100 Translational Medicine associated with Recanaclotide
Login to view more data
100 Patents (Medical) associated with Recanaclotide
Login to view more data
100 Deals associated with Recanaclotide
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetic Gastroparesis | Phase 2 | United States | 01 Oct 2014 | |
| Dyspepsia | Phase 2 | Belgium | 01 Oct 2012 | |
| Dyspepsia | Phase 2 | Netherlands | 01 Oct 2012 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free